共 10 条
[1]
Mechanism of complement activation after coronary arteryocclusion evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellu-lar origin that complex with human Clq in vivo. Rossen RD,Michael LH,Kagiyama A,et al. Circulation Research . 1988
[2]
Complement localization and mediation of ischemic in-jury in baboon myocardium. Pinckard RN,Orourbe RA,Crawford MH,et al. The Journal of Clinical Investigation . 1980
[3]
Chemotactic response to human C3a and C5a anaphyla-toxins evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. Fernandez HN,Henson PM,Otanl,A,et al. J Immunol . 1978
[4]
The control of homologous lysis. Lachmann PJ. Immunology Today . 1991
[5]
Reduction by cobra venom factor of myocardial necrosisafter coronary artery occlusion. Maroko PR,Carpenter CB,Chiariello M,et al. The Journal of Clinical Investigation . 1978
[6]
Cholesterol and atheroma lipids activate comple-ment and stimulate granulocytes:A possible mechanism for amplification of ischemic injury inatherosclerotic states. Hammerschmidt DE,Greenberg CS,Yamada O,et al. Journal of Laboratory and Clinical Medicine . 1981
[7]
Complement and neutrophil activation in the pathogenesisof ischemic myocardial injury. Crawford MH,Grover FL,Kolb WP,et al. Circulation . 1988
[8]
Regulation of complement membrane attack complex formation in my-ocardial infarction. Vakeva A,Laurila P,Meri S. American Journal of Pathology . 1993
[9]
Polymorphonuclear leukocytes and monocytes/macrophages in thepathogenesis of cerebral ischemia and stroke. Kochanek PM,Hallenbeck JM. Stroke . 1992
[10]
Reversible middle cerebral artery occlusion without craniectomy in rats. Longa EZ,Weinstein PR,Carlson S,et al. Stroke . 1989